𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer

✍ Scribed by Sridhar Mani; John W. Kugler; James A. Knost; David F. Sciortino; Joseph Gibbons; Juan C. Garcia; Rafat H. Ansari; Richard L. Schilsky; Everett E. Vokes

Book ID
110232103
Publisher
Springer US
Year
1998
Tongue
English
Weight
45 KB
Volume
16
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of menogaril in advanced
Phase II trial of menogaril in advanced colorectal cancer
✍ Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig; πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 262 KB

Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach

A phase II trial of weekly high dose con
A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
✍ Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer